Main menu

NCM 2022: Identification of *Leishmania infantum* epidemiological, drug resistance and pathogenicity biomarkers

  • Leishmania infantum is a protist parasite and causative agent of leishmaniasis, endemic to many countries world-wide, per example the Mediterranean basin.
  • Emerging drug-resistant L. infantum is one of the most relevant neglected tropical disease, as it is responsible for 12M infections w/w and more than 25,000 deaths.
  • It possesses a genome of 32 Mb distributed in 36 chromosomes and a complex network of maxi- and minicircle kinetoplasts (functionally similar to mitochondria).
  • Its genome is structurally complex, with frequent rearrangements and aneuploidies. Such changes in copy number variation (CNV) occur as a result of environment adaptation and can be potentially used as genetic biomarkers to create a genetic resistance profile.

Download the PDF

Getting started

Buy a MinION starter pack Nanopore store Sequencing service providers Channel partners

Quick links

Intellectual property Cookie policy Corporate reporting Privacy policy Terms, conditions and policies Accessibility

About Oxford Nanopore

Contact us News Media resources & contacts Investor centre Careers BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
English flag